04:15 AM EDT, 03/20/2026 (MT Newswires) -- Jonathan Allan, General Counsel and Corporate Secretary, on March 17, 2026, sold 8,895 shares in Stoke Therapeutics ( STOK ) for $285,901. Following the Form 4 filing with the SEC, Allan has control over a total of 28,836 common shares of the company, with 28,836 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/xslF345X05/form4-03192026_090304.xml